mRNA vaccines stopped the COVID-19 pandemic in its tracks. Now, they're poised to help us against the flu, rabies, cancer, ...

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Compared to daily oral pre-exposure prophylaxis (PrEP), lenacapavir reduces the number of new HIV infections by many more; causes slightly fewer serious unwanted effects; and results in little to no ...

Researchers led by Davide Incarnato at the University of Groningen have demonstrated that the FDA-approved cancer drug ...

Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses ...

ICAN attorney and antivaxxer Aaron Siri recently petitioned HHS to add 300 "injuries" to the Vaccine Injury Table for the Vaccine Injury Compensation System. It's all part or the plan to undermine and ...

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...

Moderna (MRNA +3.02%) is best known for its coronavirus vaccine, a product that generated more than $18 billion in revenue at ...

The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...

What are Peptides and why is skincare obsessed with them? Well, here we break all the information down for you.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an ...

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in rare muscle diseases, ...